AI Summary
Egg donation technology in China has established a comprehensive medical process and ethical framework within the domestic reproductive medicine field. This technology is primarily applicable to women who cannot use their own eggs due to premature ovarian failure, genetic disease carriers, age-related decline in egg quality, and other reasons. Official reproductive centers in China require donors to be between 20 and 34 years old and to pass rigorous health checks, genetic screenings, and psychological evaluations. Recipients must register at hospitals qualified to provide donor eggs and wait for an egg source, with waiting periods ranging from several months to several years, depending on factors such as blood type and matching requirements. It is important to clarify that any form of commercial egg trading is strictly prohibited in China. Donation follows the principle of voluntariness and non-compensation; recipients are only required to cover the related medical and testing costs.
Starting from a Test Report
A 32-year-old woman presented to the clinic after failing to conceive for two years. Her AMH was 0.2 ng/mL, FSH was 28 IU/L, and ultrasound showed only 1–2 antral follicles in both ovaries. Karyotype was normal, with no history of radiotherapy or chemotherapy, and no ovarian surgery. She was diagnosed with Premature Ovarian Failure (POF).
In outpatient clinics, such cases are not uncommon. When ovarian function has declined to the point where usable eggs cannot be obtained through ovarian stimulation, egg donation (donor egg IVF) becomes a significant fertility solution.
Module Q: Frequently Asked QuestionsWhat Questions Does Egg Donation Technology Address?
- Premature Ovarian Failure (POF)
- Poor Ovarian Response (POR) with repeated failed ovarian stimulation
- Carriers of genetic diseases (e.g., chromosomal translocations, single-gene disorders)
- Advanced maternal age (typically ≥ 42 years) with significantly diminished egg quality
- Iatrogenic loss of ovarian function (after radiotherapy/chemotherapy, oophorectomy)
- Severely abnormal uterine conditions (e.g., severe Asherman's syndrome adhesions, uncorrectable uterine malformations)
- Absolute contraindications for IVF (uncontrolled severe internal or surgical diseases)
- Insufficient psychological preparation, with ethical concerns regarding donor embryos
Technological Maturity and Core Data
Currently, all domestic reproductive centers qualified to provide donor eggs adhere to unified quality control standards. Donated eggs can be stored long-term after vitrification, with post-thaw survival rates ≥ 90%, stable fertilization rates of 75%–85%, and blastocyst formation rates of approximately 60%–70%. Transferring one blastocyst that has undergone PGT screening yields a clinical pregnancy rate per transfer of about 55%–65%; for blastocysts without PGT, the pregnancy rate is approximately 45%–55%.
The recipient's age significantly impacts the pregnancy rate: ≤ 35 years: approximately 60%–65%, 36–40 years: approximately 50%–55%, 41–45 years: approximately 40%–50%, and ≥ 45 years drops to 35%–40% with a miscarriage rate rising to 20%–25%.
Module C: The Doctor's PerspectiveThe Reproductive Specialist's Perspective
Recommendation: Before deciding to enter the egg donation process, it is advisable to have at least one in-depth discussion with both a reproductive specialist and a psychological counselor to clarify the gap between medical reality and personal expectations.
Differences Across Age Groups
Recipient Age Stratification
| Age Group | Clinical Pregnancy Rate (Single Blastocyst Transfer) | Miscarriage Rate | Key Considerations |
|---|---|---|---|
| ≤ 35 years | 60%–65% | 8%–12% | Greater psychological impact; attention to emotional adjustment needed |
| 36–40 years | 50%–55% | 12%–16% | Screen for comorbidities like uterine fibroids, endometrial polyps |
| 41–45 years | 40%–50% | 20%–25% | Strengthen pre-pregnancy medical evaluation and pregnancy monitoring |
| ≥ 45 years | 35%–40% | ≥ 25% | High-risk pregnancy; requires multidisciplinary consultation |
Donor Age Requirements
Domestic regulations stipulate that donors should ideally be between 20–34 years old, with the optimal donation age being 22–30 years. The donor's age is directly linked to egg quality: the euploidy rate of eggs from donors under 25 is about 70%–75%, which drops to 60%–65% for those aged 30–34. Therefore, centers usually prioritize donors under 28 years old.
Module I: Actual ProcessActual Process
The complete process of egg donation consists of two parallel tracks: the Donor Process and the Recipient Process, which need to be coordinated in terms of timing.
Donor Process
- Initial Screening: Age 20–34, good health, no family history of genetic diseases, no history of mental illness, no adverse pregnancy history.
- Medical Examination: Hormone panel (FSH, LH, E2, etc.), AMH, antral follicle count via ultrasound, infectious disease screening (Hepatitis B, C, HIV, Syphilis, etc.), karyotype analysis, carrier screening for single-gene disorders.
- Psychological Evaluation: Understand donation motivation, assess psychological state, ensure informed consent.
- Ovarian Stimulation and Egg Retrieval: Use of ovarian stimulation medications (typically GnRH antagonist protocol or short protocol), egg retrieval guided by transvaginal ultrasound.
- Egg Freezing: Mature eggs are preserved using vitrification technology and managed uniformly in the egg bank.
Recipient Process
- Medical Evaluation: Comprehensive fertility assessment (focus on uterine condition), infectious disease screening, genetic counseling.
- Registration and Waiting: Register at a reproductive center qualified for donor eggs, providing basic information like blood type, height, skin tone for matching.
- Egg Source Matching: Match egg source based on blood type (primarily ABO compatibility) and basic phenotypic information.
- Embryo Creation: Use the recipient's partner's sperm (or donor sperm) for ICSI fertilization of the donated eggs, culture to blastocyst stage.
- Embryo Transfer: After adequate endometrial preparation in the recipient (natural cycle or hormone replacement cycle), transfer 1–2 blastocysts.
- Luteal Support and Pregnancy Confirmation: Check blood HCG 12–14 days after transfer; continue luteal support until 10–12 weeks of gestation upon confirmation of pregnancy.
Timeline
| Step | Estimated Time | Notes |
|---|---|---|
| Recipient Evaluation & Registration | 1–2 weeks | Complete tests, establish file |
| Egg Source Waiting | 3 months – 2 years | Depends on blood type, matching requirements, center's egg reserve |
| Donor Ovarian Stimulation & Retrieval | 2–3 weeks | Concurrent process for donor |
| Embryo Culture + PGT (if needed) | 5–7 days + 2–3 weeks | Blastocyst culture 5–7 days, PGT requires additional 2–3 weeks |
| Embryo Transfer | 1 day | Outpatient procedure, no hospitalization needed |
| Pregnancy Confirmation | 12–14 days post-transfer | Blood HCG test |
Egg source waiting is the most uncertain step in the entire process. The shortage of egg sources is common in China. Waiting times for blood types A and B are relatively shorter, while type AB often has longer waits due to its lower population frequency. Some centers with ample egg reserves may shorten the waiting period to 3–6 months.
Module G: Most Easily Overlooked DetailsMost Easily Overlooked Details
① Psychological Preparation and Ethical Communication
Many recipients focus on the medical process but overlook psychological preparation. It is recommended to have thorough communication with your partner before starting the process and seek psychological counseling if necessary. How to inform the child about their origins in a donor egg family is also an issue that needs prior consideration.
② Individualized Endometrial Preparation
The recipient's endometrial receptivity is a key variable affecting pregnancy outcomes. In hormone replacement cycles, endometrial thickness, pattern, and blood flow need comprehensive assessment. For patients with a history of uterine procedures or thin endometrium, a hysteroscopy is recommended in advance.
③ Importance of Genetic Counseling
Although donors undergo genetic screening, there is still a residual risk of carrying recessive genetic disorders. Genetic counseling for the recipient and their partner is equally important. Expanded carrier screening (e.g., for SMA, thalassemia, deafness genes) may be necessary.
④ Standardization of Legal Documents
Egg donation in China requires signing strict informed consent forms, including the donor's consent (clarifying the purpose of donation, anonymity principle) and the recipient's consent (understanding the process, risks, ethical boundaries). It is advisable to read the relevant documents carefully before starting the process to ensure all terms are understood.
Module H: Common PitfallsCommon Pitfalls
Any form of commercial egg trading is strictly prohibited in China. Some illegal intermediaries attract young women to donate eggs with "high compensation" or charge recipients exorbitant "egg source fees." These are all illegal activities. Recipients should choose official reproductive centers qualified for donor eggs and avoid obtaining egg sources through private channels.
Official reproductive centers conduct strict screening of donors, but recipients have the right to know the donor's basic phenotypic information (blood type, height, skin tone, education level, etc.) as well as the items and results of genetic screening. Egg sources with incomplete screening should be accepted with caution.
Donor egg IVF does not always succeed on the first attempt. Even with good embryo quality, there is still a failure rate of about 40%–50%. Be mentally and financially prepared for multiple transfers. It is advisable to discuss the "maximum number of attempts" with your doctor before starting.
The older you get, the poorer the uterine condition and overall health, the lower the pregnancy rate, and the higher the obstetric risks. For patients who have already decided on egg donation, it is not recommended to delay excessively waiting for the "perfect egg source." During the waiting period, regularly monitor endometrial status and general health; do not wait passively.
Special Situations
Premature Ovarian Failure Combined with Other Etiologies
Some POF patients have concurrent autoimmune diseases (e.g., Addison's disease, thyroiditis). The primary disease needs to be controlled before egg donation, and pregnancy risks should be assessed. Testing for anti-adrenal antibodies, thyroid antibodies, and autoantibody panels is recommended.
Recurrent Implantation Failure
For patients who have failed to conceive after multiple donor egg embryo transfers, it is recommended to perform Endometrial Receptivity Testing (ERT), check for chronic endometritis, and conduct immunological evaluations to find underlying causes. Some patients may need adjustments to the endometrial preparation protocol or intrauterine infusions.
Genetic Disease Requirements
For patients requiring egg donation due to genetic diseases, it is recommended to simultaneously conduct genetic counseling and carrier screening for the partner. If necessary, perform PGT-M (monogenic disease testing) on the donor embryos. This can minimize the risk of disease in the offspring.
Conclusion: Risk ReminderRisk Reminder
Ethical Risks: Potential issues regarding the offspring's right to know due to donor anonymity; some recipients may face identity confusion.
Psychological Risks: Recipients may experience psychological落差 due to the lack of genetic connection; family communication should be prepared in advance.
Legal Risks: Obtaining egg sources through informal channels may involve legal disputes; always choose a qualified reproductive center.
Choosing egg donation is a process that requires careful decision-making. It is recommended to make your choice under the guidance of a reproductive specialist, based on your own situation, and with a full understanding of the process, conditions, and risks. For patients who meet the medical indications, egg donation is currently the most standardized and effective way to address egg source issues in China.
This article is intended for medical knowledge popularization only and does not constitute medical advice. Please consult an official reproductive center for specific plans.
Comments (0)